Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients

A. Verduri, B. Bottazzi, C. Leuzzi, R. D‘Amico, P. Boschetto, M. G. Modena, A. Mantovani, L. M. Fabbri, B. Beghé (Modena, Milan, Ferrara, Italy)

Source: Annual Congress 2011 - COPD management
Session: COPD management
Session type: Poster Discussion
Number: 253
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Verduri, B. Bottazzi, C. Leuzzi, R. D‘Amico, P. Boschetto, M. G. Modena, A. Mantovani, L. M. Fabbri, B. Beghé (Modena, Milan, Ferrara, Italy). Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients. Eur Respir J 2011; 38: Suppl. 55, 253

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016


Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

Endothelial dysfunction in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011


Renal function reserve in patients with mild and moderate chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 56s
Year: 2005

A study of neuromuscular dysfunction in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012


Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002

Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007

The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2012; 39: 51-58
Year: 2012



Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2011; 39: 51-58
Year: 2012



Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001

Are severe asthma and chronic obstructive pulmonary disease the same disease?
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006


Mechanisms of Cardiac arrhythmias in patients with chronic obstructive disease (COPD)
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018

The frequency of the cardiac arrhythmias of the patients who suffer from the chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005

Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011

Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010

Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 241s
Year: 2003

Prediction of vascular-platelet hemostasis disorders in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020